Butterfly Network Eyes $74M Payday as Midjourney Medical Unveils Full-Body Ultrasound Scanner — Butterfly Network, Inc.

Event summary

Midjourney Medical launched a full-body ultrasound scanner using 40 Butterfly Ultrasound-on-Chip™ modules under a co-development agreement.
Butterfly Network stands to receive up to $74M over five years from the partnership, per a November 2025 Form 8-K filing.
The scanner prototype features 500,000 sensors and 2 petaflops of processing power, designed for weekly consumer use.
Butterfly CEO Joseph DeVivo framed the collaboration as a step toward preventive healthcare and democratized imaging data.
Butterfly will discuss the partnership further in a TD Cowen webinar on June 18, 2026.

The big picture

Butterfly Network’s partnership with Midjourney Medical represents a bet on the growing demand for affordable, accessible imaging technology beyond traditional clinical settings. The collaboration underscores a broader industry push toward preventive healthcare, leveraging AI and semiconductor advancements to enable continuous health monitoring. With up to $74M at stake, the deal highlights the commercial potential of licensing Butterfly’s Ultrasound-on-Chip technology for non-competitive applications.

What we're watching

Commercial Viability: Whether Midjourney Medical can achieve regulatory clearance and market acceptance for its novel whole-body imaging platform.
Execution Risk: Butterfly Network’s ability to scale Ultrasound-on-Chip production to meet Midjourney’s future module demands.
Strategic Alignment: How Butterfly’s shift toward preventive healthcare aligns with broader industry trends in consumer health tech.